Reference 16 - Immediate adverse reactions to gadolinium-based MR contrast
NonrulemakingSupporting & Related MaterialFDA-2026-P-6737-0018
Document
Details
The document's own metadata, straight from regulations.gov.
- Posted
- Jun 15, 2026
- Agency
- Food and Drug Administration (FDA)